SARS_CoV_2 Infection Clinical Trials in New York

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
V
Recruiting
  • COVID-19
  • +2 more
  • Chandler, Arizona
  • +41 more
2021-11-09
Nov 9, 2021
B
Active, not recruiting
  • SARS-CoV-2 Infection
  • COVID-19
  • BNT162b2
  • Placebo
  • Athens, Alabama
  • +144 more
2021-11-16
Nov 16, 2021
B
Recruiting
  • SARS-CoV-2 Infection
  • COVID-19
  • BNT162b1
  • +3 more
  • Athens, Alabama
  • +165 more
2021-10-20
Oct 20, 2021
P
Active, not recruiting
  • Immunocompromised
  • +5 more
  • BNT162b2 (Tozinameran)
  • New York, New York
    Pfizer Inc.
2021-09-14
Sep 14, 2021
N
Recruiting
  • SARS-CoV-2 Infection
  • Moderna COVID-19 Vaccine
  • Birmingham, Alabama
  • +54 more
2021-08-06
Aug 6, 2021
T
Recruiting
  • SARS-CoV-2 Infection
  • Acute Kidney Injury
  • Placebo
  • Nicotinamide riboside
  • New York, New York
  • +3 more
2021-08-03
Aug 3, 2021
M
Completed
  • SARS-CoV-2 Infection
  • Convalescent Plasma (anti-SARS-CoV-2 plasma)
  • Non-convalescent Plasma (control plasma)
  • New York, New York
  • +3 more
2021-05-16
May 16, 2021